Latest analysis of the ELIANA trial for acute lymphocytic leukemia
3 Views
administrator
08/04/23
Dr Stefan Grupp gives a press conference at ASH 2018 about the ELIANA trial.
He diescribes how tisagenlecleucel continues to show durable remissions in paediatric and young patients with relapsed or treatment-resistant acute lymphocytic leukaemia.
Watch his interview with ecancer here:
Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php
-
Category
Show more
Facebook Comments
No comments found